BFC Planning’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
BFC Planning's DNA Position: Q3 2026 in Review
BFC Planning held its Ginkgo Bioworks (DNA) position steady in Q3 2026 at 18 shares worth $231. The position accounts for ﹤0.01% of the portfolio, ranked #3343.
BFC Planning first reported a position in DNA in Q3 2024 and has held it in 9 quarters since. The position peaked at $20.4K in Q3 2025. 128 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- BFC Planning held 18 shares of Ginkgo Bioworks worth $231 as of Q3 2026.
- BFC Planning left its Ginkgo Bioworks share count unchanged in Q3 2026.
- Ginkgo Bioworks made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3343 holding.
- BFC Planning first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Ginkgo Bioworks position peaked at $20.4K in Q3 2025.
- 128 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.